# Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

> **NCT00343252** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 712 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal
- Back Pain
- Spinal Fracture

## Interventions

- **DRUG:** teriparatide
- **DRUG:** risedronate
- **DRUG:** placebo
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00343252
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-06
- **Final completion:** 2010-06
- **Target enrollment:** 712 (ACTUAL)
- **Last updated:** 2011-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343252, "Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00343252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*